How do I suspend or resume a patient's Glooko® MIDS treatment plan?

In certain situations, a patient's Mobile Insulin Dosing System (MIDS) treatment plan may need to be temporarily suspended. When the MIDS program is suspended, the patient's MIDS Status will be updated accordingly and he or she will receive a notification in the Glooko app.

NOTE: You also have the option to end the MIDS program for a patient. To learn more, see How can a patient's Glooko MIDS program be ended?

In this article, you can learn how to:

• Suspend a MIDS treatment plan
• Resume a MIDS treatment plan

Suspend a MIDS treatment plan

1. Go to my.glooko.com and log into your Population Tracker.
2. From your Patient List, locate and click on the patient you would like to suspend.
   
   
3. From the Patient Profile, click the MIDS tab.
   
   
4. In the Treatment Plan section, click Suspend.
   
   
   
   
5. Once you click Suspend, you will be prompted with: "Are you sure you want to suspend the MIDS program for this patient?" Click Cancel to cancel the suspension or Suspend Program to confirm.
   
   
6. When the MIDS program is suspended, the patient's MIDS Status will change from "Active: In Progress" to "Inactive: Suspended By Provider." The patient will receive an in-app notification indicating that MIDS has been suspended with instructions to contact his or her provider.     
   
   
7. In the Patient Adjustments section, you will see the date that the MIDS treatment plan was suspended and who initiated the suspension (i.e. provider, patient or program). 
   
   

Resume a MIDS treatment plan

1. From the Patient Profile, click the MIDS tab.
2. Click Resume to reinitiate the treatment plan.
   
   
3. Next, you will be required to review the current treatment plan. Here, you can Choose a different treatment plan or make changes to the existing plan.
   
   

4. Review and change (if needed):

   • Insulin Type and Strength
   • Titration Period
   • End Date
   • Minimum Required Readings.
   • Fasting Target Range for blood glucose.
   • Adjustments for blood glucose readings below and above specified fasting blood glucose limits.
     • Click Add New Row to add an additional dose adjustment rule.
   • Patient Safety Notifications
     
     NOTE: For this tutorial, we have made changes to the Maximum Dose for this patient.
   • Patient Reminders
   • Contact Information
     
     
5. Once you have reviewed the treatment plan and have made any necessary changes, click Save.
6. Next, a summary of the updated treatment plan will display. Click Go Back to return to the Edit Treatment Plan screen or Update Treatment Plan to initialize the plan.
7. The MIDS Status will change from "Inactive: Suspended By Provider" to "Inactive: Pending."
8. The patient will receive an in-app notification indicating that you have made a change to his or her treatment plan. Once the treatment plan updates have been accepted by the patient, the MIDS Status will change from "Inactive: Pending" to "Active: In Progress."
9. In the Patient Adjustments section, you will see the date that the MIDS treatment plan was revised and the date the revision was accepted by the patient.
   
   

*Please note: MIDS is currently only available in the U.S.